<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   COVID-19: Extracorporeal membrane oxygenation (ECMO)
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       COVID-19: Extracorporeal membrane oxygenation (ECMO)
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        COVID-19: Extracorporeal membrane oxygenation (ECMO)
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Authors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Michael G Fitzsimons, MD
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Jerome Crowley, MD, MPH
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Michael F O'Connor, MD, FCCM
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Jonathan B Mark, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Nancy A Nussmeier, MD, FAHA
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Geraldine Finlay, MD
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Nov 22, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H2505704597">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         The pneumonia associated with coronavirus disease 2019 (COVID-19) can lead to acute respiratory failure with profound hypoxemia requiring endotracheal intubation and mechanical ventilation. Myocardial injury associated with COVID-19 may also lead to cardiogenic shock unresponsive to medical management. Patients who do not respond to optimal conventional therapy may be candidates for management with extracorporeal membrane oxygenation (ECMO) in institutions with appropriate resources (equipment and personnel).
        </p>
        <p>
         This topic will address COVID-19-specific issues associated with the use of ECMO. General concepts regarding ECMO use in adult patients are discussed in other topics.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/1625.html" rel="external">
          "Extracorporeal life support in adults in the intensive care unit: Overview"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/134266.html" rel="external">
          "Extracorporeal life support in adults: Management of venovenous extracorporeal membrane oxygenation (V-V ECMO)"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/134279.html" rel="external">
          "Extracorporeal life support in adults: Management of venoarterial extracorporeal membrane oxygenation (V-A ECMO)"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/139245.html" rel="external">
          "Extracorporeal life support in adults in the intensive care unit: Vascular complications"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/134496.html" rel="external">
          "Extracorporeal life support in adults: Extracorporeal carbon dioxide removal (ECCO2R)"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/134279.html" rel="external">
          "Extracorporeal life support in adults: Management of venoarterial extracorporeal membrane oxygenation (V-A ECMO)"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/139245.html" rel="external">
          "Extracorporeal life support in adults in the intensive care unit: Vascular complications"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/131002.html" rel="external">
          "Extracorporeal life support in adults in the intensive care unit: The role of transesophageal echocardiography (TEE)"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/115472.html" rel="external">
          "Intraoperative problems after cardiopulmonary bypass", section on 'Extracorporeal membrane oxygenation'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H4093947989">
         <span class="h1">
          TERMINOLOGY
         </span>
         <span class="headingEndMark">
          —
         </span>
         Extracorporeal membrane oxygenation (ECMO) is a form of temporary extracorporeal life support that provides gas exchange for patients with respiratory failure and/or cardiac support for patients with cardiac or circulatory failure  (
         <a class="graphic graphic_table graphicRef140283" href="/z/d/graphic/140283.html" rel="external">
          table 1
         </a>
         ). Venovenous (V-V) ECMO (for respiratory failure) or venoarterial (V-A) ECMO (for cardiac failure) are the two most common forms of ECMO used in the intensive care unit (ICU), although more complex configurations are sometimes employed.
        </p>
        <p class="headingAnchor" id="H3163482976">
         <span class="h1">
          INDICATIONS AND CONTRAINDICATIONS
         </span>
        </p>
        <p class="headingAnchor" id="H272598467">
         <span class="h2">
          Indications
         </span>
         <span class="headingEndMark">
          —
         </span>
         Indications for extracorporeal membrane oxygenation (ECMO) in patients with COVID-19 are similar to those for other conditions [
         <a href="#rid1">
          1-7
         </a>
         ]. Patients with COVID-19 who fail conventional therapy for acute respiratory failure or acute cardiac failure may be candidates for venovenous (V-V) ECMO and venoarterial (V-A) ECMO, respectively  (
         <a class="graphic graphic_figure graphicRef140301" href="/z/d/graphic/140301.html" rel="external">
          figure 1
         </a>
         and
         <a class="graphic graphic_figure graphicRef140295" href="/z/d/graphic/140295.html" rel="external">
          figure 2
         </a>
         ) [
         <a href="#rid8">
          8,9
         </a>
         ]. Among the indications, COVID-19-related acute respiratory distress syndrome (ARDS) is the most common indication. Details regarding criteria for select indications and evaluation of suitability for ECMO are discussed separately  (
         <a class="graphic graphic_table graphicRef140283" href="/z/d/graphic/140283.html" rel="external">
          table 1
         </a>
         ):
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/1625.html" rel="external">
          "Extracorporeal life support in adults in the intensive care unit: Overview", section on 'Type of support needed'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/134266.html" rel="external">
          "Extracorporeal life support in adults: Management of venovenous extracorporeal membrane oxygenation (V-V ECMO)", section on 'Clinical applications'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/134279.html" rel="external">
          "Extracorporeal life support in adults: Management of venoarterial extracorporeal membrane oxygenation (V-A ECMO)", section on 'Clinical applications'
         </a>
         .)
        </p>
        <p>
        </p>
        <p>
         Data to support use of ECMO in patients with COVID-19 are derived from observational series in patients with COVID-19 [
         <a href="#rid1">
          1,5,7,8,10-13
         </a>
         ], as well as indirect data from patients with non-COVID-related illnesses including Middle East respiratory syndrome coronavirus (MERS-CoV) in 2012 and influenza A (H1N1) in 2009 [
         <a href="#rid14">
          14-18
         </a>
         ]. Evidence supporting the efficacy of V-V or V-A ECMO is discussed in separate topics:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/134266.html" rel="external">
          "Extracorporeal life support in adults: Management of venovenous extracorporeal membrane oxygenation (V-V ECMO)", section on 'Clinical applications'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/134279.html" rel="external">
          "Extracorporeal life support in adults: Management of venoarterial extracorporeal membrane oxygenation (V-A ECMO)", section on 'Clinical applications'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2784139446">
         <span class="h3">
          Venovenous (V-V) ECMO
         </span>
         <span class="headingEndMark">
          —
         </span>
         During V-V ECMO, blood is removed from the venous system (eg, iliac vein or superior vena cava), passed through an artificial membrane lung, and then returned back to the venous system (eg, superior vena cava or right atrium), where it passes through the lungs  (
         <a class="graphic graphic_figure graphicRef140301" href="/z/d/graphic/140301.html" rel="external">
          figure 1
         </a>
         ). V-V ECMO is an option to treat COVID-19-related ARDS that is refractory to conventional ventilator management. Indications for and configurations that may be selected for V-V ECMO are discussed separately:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/134266.html" rel="external">
          "Extracorporeal life support in adults: Management of venovenous extracorporeal membrane oxygenation (V-V ECMO)", section on 'Clinical applications'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/134266.html" rel="external">
          "Extracorporeal life support in adults: Management of venovenous extracorporeal membrane oxygenation (V-V ECMO)", section on 'Venovenous ECMO configurations and sites'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2997129423">
         <span class="h3">
          Venoarterial (V-A) ECMO
         </span>
         <span class="headingEndMark">
          —
         </span>
         During V-A ECMO, blood is removed from the venous system (eg, iliac vein or superior vena cava), passed through an artificial membrane lung, and then returned to the arterial system (eg, femoral or right subclavian artery)  (
         <a class="graphic graphic_figure graphicRef140295" href="/z/d/graphic/140295.html" rel="external">
          figure 2
         </a>
         ), thereby providing both cardiac and pulmonary support [
         <a href="#rid19">
          19
         </a>
         ]. Use of V-A ECMO in patients with COVID-19 is reserved for those with severe acute cardiac dysfunction and hypoxemia refractory to support with V-V ECMO. Clinical conditions in which this may apply include cardiogenic shock (due to several different etiologies), right ventricle dysfunction, acute decompensated pulmonary vascular disease, or cardiopulmonary resuscitation [
         <a href="#rid3">
          3,8,20
         </a>
         ].
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/127537.html" rel="external">
          "COVID-19: Evaluation and management of cardiac disease in adults"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/127533.html" rel="external">
          "COVID-19: Myocardial infarction and other coronary artery disease issues"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/134279.html" rel="external">
          "Extracorporeal life support in adults: Management of venoarterial extracorporeal membrane oxygenation (V-A ECMO)", section on 'Clinical applications'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1083950293">
         <span class="h2">
          Contraindications
         </span>
         <span class="headingEndMark">
          —
         </span>
         Contraindications to both V-V and V-A ECMO are listed in the table  (
         <a class="graphic graphic_table graphicRef140303" href="/z/d/graphic/140303.html" rel="external">
          table 2
         </a>
         ).
        </p>
        <p>
         When resources are limited, patients with minor or no comorbidities are typically prioritized [
         <a href="#rid1">
          1,8
         </a>
         ]. When capacity of a hospital system is overwhelmed during a pandemic surge, limitations of institutional or regional resources may contraindicate use of ECMO [
         <a href="#rid8">
          8
         </a>
         ]. (See
         <a class="local">
          'Resource considerations'
         </a>
         below.)
        </p>
        <p>
         Prone positioning is not a contraindication to ECMO in patients with COVID-19 (especially when the patient is cannulated via a jugular vein exclusively for V-V ECMO). (See
         <a class="local">
          'Prone positioning'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H2419506319">
         <span class="h1">
          CATHETER CONFIGURATIONS AND CANNULATION
         </span>
        </p>
        <p class="headingAnchor" id="H3029820931">
         <span class="h2">
          Infectious precautions for vascular cannulation
         </span>
         <span class="headingEndMark">
          —
         </span>
         If available, use of an airborne isolation room (ie, negative pressure room) is ideal for vascular cannulation in a patient with COVID-19. Notably, insertion of extracorporeal membrane oxygenation (ECMO) cannulae may be challenging in patients with COVID-19 who develop rapid deterioration [
         <a href="#rid21">
          21
         </a>
         ]. Institution of emergency ECMO requires two separate teams, with one managing sudden clinical changes, while another team accomplishes vascular cannulation and establishes ECMO. Full personal protective equipment (PPE) is necessary for the procedure.
        </p>
        <p>
         Infectious precautions necessary in a health care setting are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/130296.html" rel="external">
          "COVID-19: General approach to infection prevention in the health care setting"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/140910.html" rel="external">
          "Overview of infection control during anesthetic care", section on 'Considerations during aerosol-generating procedures'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H894011033">
         <span class="h2">
          ECMO configurations
         </span>
         <span class="headingEndMark">
          —
         </span>
         Techniques and configurations for ECMO are similar to those in non-COVID-19 patients  (
         <a class="graphic graphic_table graphicRef128250" href="/z/d/graphic/128250.html" rel="external">
          table 3
         </a>
         and
         <a class="graphic graphic_diagnosticimage graphicRef116518" href="/z/d/graphic/116518.html" rel="external">
          image 1
         </a>
         and
         <a class="graphic graphic_diagnosticimage graphicRef116234" href="/z/d/graphic/116234.html" rel="external">
          image 2
         </a>
         and
         <a class="graphic graphic_diagnosticimage graphicRef116454" href="/z/d/graphic/116454.html" rel="external">
          image 3
         </a>
         and
         <a class="graphic graphic_diagnosticimage graphicRef128288" href="/z/d/graphic/128288.html" rel="external">
          image 4
         </a>
         and
         <a class="graphic graphic_diagnosticimage graphicRef128289" href="/z/d/graphic/128289.html" rel="external">
          image 5
         </a>
         and
         <a class="graphic graphic_diagnosticimage graphicRef128290" href="/z/d/graphic/128290.html" rel="external">
          image 6
         </a>
         and
         <a class="graphic graphic_diagnosticimage graphicRef128291" href="/z/d/graphic/128291.html" rel="external">
          image 7
         </a>
         and
         <a class="graphic graphic_diagnosticimage graphicRef128292" href="/z/d/graphic/128292.html" rel="external">
          image 8
         </a>
         ) [
         <a href="#rid3">
          3,22
         </a>
         ]. For venovenous (V-V) ECMO we use a two-site femoral vein-internal jugular vein approach, if feasible  (
         <a class="graphic graphic_figure graphicRef140301" href="/z/d/graphic/140301.html" rel="external">
          figure 1
         </a>
         ) [
         <a href="#rid8">
          8
         </a>
         ]. For venoarterial (V-A) ECMO, we use an approach that has femoral venous drainage and femoral or subclavian arterial reinfusion  (
         <a class="graphic graphic_figure graphicRef140295" href="/z/d/graphic/140295.html" rel="external">
          figure 2
         </a>
         ). Further details regarding these configurations are described separately:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/134266.html" rel="external">
          "Extracorporeal life support in adults: Management of venovenous extracorporeal membrane oxygenation (V-V ECMO)", section on 'Catheter insertion'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/134279.html" rel="external">
          "Extracorporeal life support in adults: Management of venoarterial extracorporeal membrane oxygenation (V-A ECMO)", section on 'Catheter insertion'
         </a>
         .)
        </p>
        <p>
        </p>
        <p>
         These configurations are preferred in patients with COVID-19 since cannulation is often needed under urgent or emergent circumstances, and the vessels are percutaneously accessible at the bedside. In addition, these configurations obviate the need for patient transport to a fluoroscopy suite. Avoiding transport of patients for catheter placement under fluoroscopy minimizes the number of health care personnel who are exposed to infection risk and avoids disconnection from the intensive care unit (ICU) ventilator that can result in alveolar derecruitment and cardiopulmonary instability [
         <a href="#rid23">
          23
         </a>
         ].
        </p>
        <p>
         We typically use transesophageal echocardiography (TEE) at the bedside to ensure correct positioning of the cannulae. Although TEE in nonintubated patients is considered to be an aerosol-generating procedure, the infectious risk is reduced after endotracheal intubation since the airway has been secured. Furthermore, appropriate PPE is donned by the echocardiographer, and protection for the ultrasound equipment can be used [
         <a href="#rid24">
          24-29
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/131002.html" rel="external">
          "Extracorporeal life support in adults in the intensive care unit: The role of transesophageal echocardiography (TEE)"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5320.html" rel="external">
          "Transesophageal echocardiography: Indications, complications, and normal views", section on 'COVID-19 precautions'
         </a>
         .)
        </p>
        <p>
         Other peripheral cannulation strategies are shown in the table  (
         <a class="graphic graphic_table graphicRef128250" href="/z/d/graphic/128250.html" rel="external">
          table 3
         </a>
         ). For patients with COVID-19 who may require ECMO support, we perform point-of-care ultrasound and/or transthoracic echocardiography to detect development of thrombosis at potential cannulation sites [
         <a href="#rid30">
          30
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H207534909">
         <span class="h1">
          COVID-SPECIFIC CONCERNS FOR ECMO MANAGEMENT
         </span>
         <span class="headingEndMark">
          —
         </span>
         Discussed below are considerations specific for extracorporeal membrane oxygenation (ECMO) management in patients with COVID-19 [
         <a href="#rid8">
          8
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H2471627907">
         <span class="h2">
          Oxygenation and ventilation
         </span>
         <span class="headingEndMark">
          —
         </span>
         Goals for maintaining oxygenation and ventilation and managing circuits during venovenous (V-V) and venoarterial (V-A) ECMO are the same as those for non-COVID-19 patients. Details are discussed separately:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/134266.html" rel="external">
          "Extracorporeal life support in adults: Management of venovenous extracorporeal membrane oxygenation (V-V ECMO)", section on 'Initial settings and titration'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/134266.html" rel="external">
          "Extracorporeal life support in adults: Management of venovenous extracorporeal membrane oxygenation (V-V ECMO)", section on 'Daily assessment and circuit monitoring'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/134279.html" rel="external">
          "Extracorporeal life support in adults: Management of venoarterial extracorporeal membrane oxygenation (V-A ECMO)", section on 'Initial settings and titration'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/134279.html" rel="external">
          "Extracorporeal life support in adults: Management of venoarterial extracorporeal membrane oxygenation (V-A ECMO)", section on 'Daily assessment and circuit monitoring'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2943936724">
         <span class="h2">
          Maintenance of anticoagulation
         </span>
         <span class="headingEndMark">
          —
         </span>
         Anticoagulation is particularly important since both COVID-19 and ECMO support are risk factors for thrombosis. As with all patients on ECMO, continuous anticoagulation is required to maintain the ECMO circulation [
         <a href="#rid8">
          8,31
         </a>
         ].
        </p>
        <p>
         However, there is no consensus regarding optimal intensity of anticoagulation in patients with COVID-19 who require ECMO support. Experts use different agents and different parameters to achieve anticoagulation, always with vigilant monitoring to ensure continuous anticoagulation and maintenance of adequate ECMO flow. We use a continuous infusion of
         <a class="drug drug_general" data-topicid="8518" href="/z/d/drug information/8518.html" rel="external">
          unfractionated heparin
         </a>
         for patients with COVID-19 on ECMO in our center, with an activated partial thromboplastin time (aPTT) target that is 70 to 100 seconds or at least 1.5 times the institutional control value for V-V ECMO or 2.0 times the control value for V-A ECMO. Some centers select a higher target (eg, 2.0 to 2.5 times the institutional aPTT control value) [
         <a href="#rid32">
          32
         </a>
         ]. However, other centers administer a heparin infusion to a target aPTT of 50 to 60 seconds and withhold anticoagulation up to several days in patients who have a relative contraindication to anticoagulation unless the appearance of clots in the oxygenator compels initiation of anticoagulation.
        </p>
        <p>
         Activated clotting time (ACT) or viscoelastic tests (eg, thromboelastography [TEG] or rotational thromboelastometry [ROTEM]) may be employed to guide anticoagulation [
         <a href="#rid33">
          33-36
         </a>
         ]. Although not routine, some experts perform daily transthoracic echocardiography or point-of-care ultrasonography in patients with COVID-19 on ECMO to monitor for early signs of acute cor pulmonale due to pulmonary embolism [
         <a href="#rid10">
          10,20,37
         </a>
         ].
        </p>
        <p>
         Further details regarding anticoagulation management for patients with COVID-19 and on ECMO are provided separately.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/127926.html" rel="external">
          "COVID-19: Hypercoagulability", section on 'Clotting of intravascular access devices'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/134266.html" rel="external">
          "Extracorporeal life support in adults: Management of venovenous extracorporeal membrane oxygenation (V-V ECMO)", section on 'Thrombosis and thromboembolism'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/134279.html" rel="external">
          "Extracorporeal life support in adults: Management of venoarterial extracorporeal membrane oxygenation (V-A ECMO)", section on 'Cardiac or aortic thrombosis'
         </a>
         .)
        </p>
        <p>
        </p>
        <p>
         Management of anticoagulation during ECMO in non-COVID-19 patients is also discussed separately.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/134266.html" rel="external">
          "Extracorporeal life support in adults: Management of venovenous extracorporeal membrane oxygenation (V-V ECMO)", section on 'Anticoagulation'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/134279.html" rel="external">
          "Extracorporeal life support in adults: Management of venoarterial extracorporeal membrane oxygenation (V-A ECMO)", section on 'Anticoagulation'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3217606693">
         <span class="h2">
          Sedation
         </span>
         <span class="headingEndMark">
          —
         </span>
         As with other mechanically ventilated patients with acute respiratory distress syndrome (ARDS), sedation should be titrated to individual patient needs. Some patients with COVID-19 require more sedation than most critically ill patients due to their younger age, higher respiratory drive, increased sedative drug clearance caused by other medications, and a particularly intense inflammatory response [
         <a href="#rid38">
          38-40
         </a>
         ]. Notably, it may be particularly difficult to wean moderate to heavy sedation during ECMO support of a patient with COVID-19 with severe agitation due to risk of dislodgement of ECMO cannulae, shifts in venous return affecting ECMO flows, or ventilator dyssynchrony [
         <a href="#rid38">
          38,39
         </a>
         ]. On the other hand, some centers will routinely lighten sedation if it is well tolerated and even extubate patients on V-V or V-A ECMO. (See
         <a class="medical medical_review" href="/z/d/html/127419.html" rel="external">
          "COVID-19: Management of the intubated adult", section on 'Sedation and analgesia'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2224636701">
         <span class="h2">
          Prone positioning
         </span>
         <span class="headingEndMark">
          —
         </span>
         Prone positioning for ventilation of patients with COVID-19 with respiratory failure is known to be advantageous during the period of mechanical ventilation before initiation of ECMO. Although prone positioning is not usually performed during ECMO support, it may be used in selected patients, particularly if ECMO weaning is necessary due to bleeding or cannulation site infection [
         <a href="#rid41">
          41
         </a>
         ]. Under these circumstances, studies have shown that the prone position improves oxygenation and is safe during ECMO in patients with COVID-19 with minimal risk of cannula dislodgement [
         <a href="#rid42">
          42-44
         </a>
         ].
        </p>
        <p>
         Data supporting prone positioning in patients with COVID-19 who are not receiving ECMO are provided separately. (See
         <a class="medical medical_review" href="/z/d/html/127419.html" rel="external">
          "COVID-19: Management of the intubated adult", section on 'Low tidal volume ventilation in the prone position'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2606916591">
         <span class="h2">
          V-V to V-A ECMO conversion
         </span>
         <span class="headingEndMark">
          —
         </span>
         Occasionally, conversion of V-V ECMO to V-A ECMO is appropriate in selected patients with COVID-19 [
         <a href="#rid8">
          8,11
         </a>
         ]. This includes patients who develop cardiopulmonary failure with inadequate tissue perfusion or shock manifested by hypotension and low cardiac output despite adequate intravascular volume and treatment of vasoplegia [
         <a href="#rid45">
          45
         </a>
         ]. This may be due to right ventricular dysfunction in patients with severe ARDS or pulmonary embolism [
         <a href="#rid37">
          37,46,47
         </a>
         ], persistent malignant arrhythmias, or cardiogenic shock in patients with acute myocardial infarction or myocarditis [
         <a href="#rid19">
          19,48
         </a>
         ]. In addition, in some patients with severe hypoxemia despite V-V ECMO, we consider switching to V-A ECMO to improve oxygenation.
        </p>
        <p>
         Details regarding management of coexistent heart failure in patients on V-V ECMO or coexistent respiratory failure in patients on V-A ECMO are provided separately:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/134266.html" rel="external">
          "Extracorporeal life support in adults: Management of venovenous extracorporeal membrane oxygenation (V-V ECMO)", section on 'Managing concomitant cardiac failure'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/134279.html" rel="external">
          "Extracorporeal life support in adults: Management of venoarterial extracorporeal membrane oxygenation (V-A ECMO)", section on 'Concomitant respiratory failure'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2578323440">
         <span class="h2">
          Tracheostomy
         </span>
         <span class="headingEndMark">
          —
         </span>
         Tracheostomy is often considered after initiation of ECMO in patients who have respiratory failure without a COVID-19 diagnosis, as this may improve patient comfort and allow lightening of sedation. However, in patients with COVID-19, tracheostomy may be reasonably deferred for up to 14 days or longer since aerosol generation will be increased during and following this procedure. Also, sedation requirements may remain high despite presence of a tracheostomy rather than an orotracheal tube [
         <a href="#rid8">
          8,38,49
         </a>
         ]. COVID-19-secific issues for tracheostomy are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/127419.html" rel="external">
          "COVID-19: Management of the intubated adult", section on 'Tracheostomy'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/4389.html" rel="external">
          "Tracheostomy: Rationale, indications, and contraindications", section on 'COVID-19'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/131519.html" rel="external">
          "Tracheostomy in adults: Techniques and intraoperative complications", section on 'COVID-19'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H4100346342">
         <span class="h2">
          Duration of support and ECMO weaning
         </span>
         <span class="headingEndMark">
          —
         </span>
         In our experience, longer durations of ECMO support may be necessary in patients with COVID-19 compared with non-COVID-19 patients. As such, we perform continuous risk-benefit evaluation of ECMO therapy over time [
         <a href="#rid1">
          1,8
         </a>
         ]. Some centers have reported use of ECMO for as long as three to six weeks [
         <a href="#rid1">
          1,5,10,50
         </a>
         ]. For patients who improve, our institutional weaning protocols are shown in the algorithms, although such protocols vary by institution  (
         <a class="graphic graphic_algorithm graphicRef128540" href="/z/d/graphic/128540.html" rel="external">
          algorithm 1
         </a>
         and
         <a class="graphic graphic_algorithm graphicRef131446" href="/z/d/graphic/131446.html" rel="external">
          algorithm 2
         </a>
         ) [
         <a href="#rid8">
          8,10,51
         </a>
         ]. Although definitions of futility are institution specific, some centers consider returning to conventional management if no lung or cardiac recovery is noted after approximately 21 days (sometimes longer), while others consider early lung transplantation referral, especially when patients have single-organ respiratory failure [
         <a href="#rid52">
          52
         </a>
         ]. In some patients, referral for lung transplantation is appropriate, and successful transplantation has been reported [
         <a href="#rid52">
          52
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3591093064">
         <span class="h1">
          COMPLICATIONS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The complications of extracorporeal membrane oxygenation (ECMO) in patients with COVID-19 are similar to those in non-COVID-19 patients. These complications are listed in the table  (
         <a class="graphic graphic_table graphicRef140676" href="/z/d/graphic/140676.html" rel="external">
          table 4
         </a>
         ). However, bleeding and possibly thrombosis may be more common in patients with COVID-19 than in non-COVID-19 patients undergoing ECMO, but accurate data are lacking:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Bleeding rates may be higher in patients with COVID-19 than in other populations receiving ECMO. One report suggested a high rate of anticoagulation-related intracranial hemorrhage in patients receiving venovenous (V-V) ECMO for COVID-19-related acute respiratory distress syndrome (ARDS) [
         <a href="#rid33">
          33
         </a>
         ]. Another study reported bleeding events in 29 percent of patients with COVID-19 receiving ECMO [
         <a href="#rid53">
          53
         </a>
         ]; in this study, bleeding events, particularly intracranial hemorrhage, were associated with mortality (adjusted odds ratio 2.91, 95% CI 1.94-4.4).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         It is unclear whether thrombosis (including intracardiac thrombus) occurs at a higher rate in patients with COVID-19 compared with non-COVID-19 patients [
         <a href="#rid54">
          54-56
         </a>
         ]. One study reported that thrombotic events occurred in 16 percent of patients with COVID-19, but these events were not associated with mortality [
         <a href="#rid53">
          53
         </a>
         ]. We routinely employ point-of-care vascular or cardiac ultrasound and/or transthoracic echocardiography during ECMO support to detect peripheral venous, arterial, or cardiac thrombi that may complicate vascular access or ECMO function [
         <a href="#rid30">
          30
         </a>
         ].
        </p>
        <p>
        </p>
        <p>
         Further details discussing complications of ECMO are provided in separate topics:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/1625.html" rel="external">
          "Extracorporeal life support in adults in the intensive care unit: Overview", section on 'Complications'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/134266.html" rel="external">
          "Extracorporeal life support in adults: Management of venovenous extracorporeal membrane oxygenation (V-V ECMO)", section on 'Complications'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/134279.html" rel="external">
          "Extracorporeal life support in adults: Management of venoarterial extracorporeal membrane oxygenation (V-A ECMO)", section on 'V-A ECMO-specific complications'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3232553848">
         <span class="h1">
          PROGNOSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Mortality of patients with COVID-19 on extracorporeal membrane oxygenation (ECMO) support are comparable to or slightly higher than that of non-COVID-19 patients on ECMO support.
        </p>
        <p>
         Early reports from China and Europe had noted very high mortality rates for patients with COVID-19 on ECMO (&gt;80 percent) [
         <a href="#rid57">
          57,58
         </a>
         ]. However, subsequent studies have noted more encouraging results (26 to 50 percent mortality) [
         <a href="#rid1">
          1,10,12,22,50,59-66
         </a>
         ]. A 2022 meta-analysis of 134 studies that included 58,472 patients with COVID-19 reported that the 4044 patients who received ECMO (6.9 percent) had an in-hospital mortality of 39 percent [
         <a href="#rid65">
          65
         </a>
         ]. A subgroup analysis of six studies included in this meta-analysis noted that patients with COVID-19 on ECMO had slightly higher mortality than patients with influenza on ECMO (44 versus 38 percent; risk ratio [RR] 1.34, 95% CI 1.05-1.7). These results are comparable to those in adult patients receiving ECMO support for acute respiratory distress syndrome (ARDS) due to other diagnoses [
         <a href="#rid60">
          60,61,67
         </a>
         ]. In a meta-analysis of 42 observational studies, prognostic factors were similar to non-COVID-19 patients receiving ECMO (eg, age, comorbidities) [
         <a href="#rid68">
          68
         </a>
         ]; other factors included longer duration of symptoms, longer duration of invasive mechanical ventilation, higher partial pressure of arterial carbon dioxide, higher driving pressure, and less previous experience with ECMO. Prognosis of non-COVID-19 patients receiving ECMO is discussed in detail separately. (See
         <a class="medical medical_review" href="/z/d/html/1625.html" rel="external">
          "Extracorporeal life support in adults in the intensive care unit: Overview", section on 'Prognosis and long-term outcomes'
         </a>
         .)
        </p>
        <p>
         Patients with COVID-19 who successfully wean from ECMO typically spend a prolonged period of time in the intensive care unit (ICU), often on mechanical ventilation. Such patients are at risk of developing long-term sequalae associated with ARDS, including post-intensive care syndrome (PICS) [
         <a href="#rid38">
          38,50,69,70
         </a>
         ]. More detailed discussions of long-term outcomes in these patient populations are available in separate topics. (See
         <a class="medical medical_review" href="/z/d/html/1601.html" rel="external">
          "Acute respiratory distress syndrome: Prognosis and outcomes in adults"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/88330.html" rel="external">
          "Post-intensive care syndrome (PICS) in adults: Clinical features and diagnostic evaluation"
         </a>
         .)
        </p>
        <p>
         Limited data describe the outcome in pregnancy. In a systematic review of observational case series reporting outcomes in pregnant females receiving ECMO due to COVID-19, the maternal survival was &gt;80 percent and fetal survival was 67.9 percent [
         <a href="#rid71">
          71
         </a>
         ]. Whether these data apply to patients undergoing ECMO due to COVID-19 from emerging strains is unknown.
        </p>
        <p class="headingAnchor" id="H674769765">
         <span class="h1">
          RESOURCE CONSIDERATIONS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Extracorporeal membrane oxygenation (ECMO) is a resource-intensive therapy requiring a multidisciplinary team of experienced medical professionals with training and expertise in initiation, maintenance, and discontinuation of ECMO [
         <a href="#rid1">
          1,2,8,10,20,51,57,72-76
         </a>
         ]. Competent planning, resource allocation, and infection control are necessary to assure that ECMO is appropriately used. Thus, it is appropriate that during surges in COVID-19, institutions do not establish a new ECMO program but rather establish consulting and referral relationships with larger health care systems when anticipating that a marked increase in COVID-19 hospitalizations will occur.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Goals
         </strong>
         – In preparation for patient surges of COVID-19, we focus on personnel, equipment, facilities, and support systems to provide [
         <a href="#rid8">
          8,11,22,77-79
         </a>
         ]:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Assessment of appropriate and safe transfers of critically ill patients from other institutions for ECMO support
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Management of resource-intensive daily care for patients receiving ECMO
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Optimal care of patients with COVID-19 with severe acute respiratory distress syndrome (ARDS) and/or cardiac failure
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Personnel
         </strong>
         – Availability of a multidisciplinary team with previous experience managing patients with ECMO is critically important for a successful program. This includes clinicians in several specialties (eg, surgeons, intensivists, anesthesiologists) as well as nurses, physician assistants, nurse practitioners, respiratory therapists, and/or perfusionist technologists. All team members require education regarding anesthetic, surgical, and critical care management of patients with COVID-19, including the need to use appropriate personal protective equipment (PPE) [
         <a href="#rid8">
          8
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/1625.html" rel="external">
          "Extracorporeal life support in adults in the intensive care unit: Overview", section on 'Staffing (ECMO teams)'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/127501.html" rel="external">
          "COVID-19: Infection prevention for persons with SARS-CoV-2 infection", section on 'Infection prevention in the health care setting'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Equipment
         </strong>
         – Inventory of available durable and disposable supplies and equipment for initiation and maintenance of ECMO therapy should be determined, with plans for replacement if inventory becomes rapidly depleted during a regional pandemic surge of critically ill patients with COVID-19. Such planning should include routine ECMO maintenance and potential need for emergency exchange of a clotted ECMO oxygenator or for conversion of venovenous (V-V) ECMO to venoarterial (V-A) ECMO. (See
         <a class="local">
          'Maintenance of anticoagulation'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Planning for decontamination of ECMO equipment after use is also necessary. Programs able to offer ECMO for patients with COVID-19 should also be able to manage availability of this support for other indications (eg, cardiogenic shock from myocardial infarction, heart transplant, lung transplant, or severe ARDS from non-COVID-19 disease).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Facilities
         </strong>
         – Placement of patients with COVID-19 on ECMO support in a single intensive care unit (ICU) location within a facility consolidates expertise of personnel with experience in ECMO and reduces exposure of additional medical personnel to infection risk.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1451812871">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/126613.html" rel="external">
          "Society guideline links: COVID-19 – Index of guideline topics"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H4032738857">
         <span class="h1">
          INFORMATION FOR PATIENTS
         </span>
         <span class="headingEndMark">
          —
         </span>
         UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5
         <sup>
          th
         </sup>
         to 6
         <sup>
          th
         </sup>
         grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10
         <sup>
          th
         </sup>
         to 12
         <sup>
          th
         </sup>
         grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.
        </p>
        <p>
         Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Basics topics (see
         <a class="medical medical_basics" href="/z/d/html/126678.html" rel="external">
          "Patient education: COVID-19 overview (The Basics)"
         </a>
         and
         <a class="medical medical_basics" href="/z/d/html/134964.html" rel="external">
          "Patient education: Extracorporeal membrane oxygenation (ECMO) (The Basics)"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H19601420">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Terminology
         </strong>
         – Extracorporeal membrane oxygenation (ECMO) provides temporary gas exchange for patients with respiratory failure and/or cardiac support for patients with cardiac or circulatory failure  (
         <a class="graphic graphic_table graphicRef140283" href="/z/d/graphic/140283.html" rel="external">
          table 1
         </a>
         ). (See
         <a class="local">
          'Terminology'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Indications
         </strong>
         <strong>
          and contraindications
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Indications for ECMO in patients with COVID-19 are similar to indications in other conditions. Failure of conventional therapy for acute respiratory failure due to acute respiratory distress syndrome (ARDS) is the most common indication for venovenous (V-V) ECMO  (
         <a class="graphic graphic_figure graphicRef140301" href="/z/d/graphic/140301.html" rel="external">
          figure 1
         </a>
         ). Less commonly, patients with acute cardiac failure (eg, due to acute myocardial infarction) are candidates for venoarterial (V-A) ECMO  (
         <a class="graphic graphic_figure graphicRef140295" href="/z/d/graphic/140295.html" rel="external">
          figure 2
         </a>
         ). Patient selection for these ECMO modes is discussed in detail separately.
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/1625.html" rel="external">
          "Extracorporeal life support in adults in the intensive care unit: Overview", section on 'Type of support needed'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/134266.html" rel="external">
          "Extracorporeal life support in adults: Management of venovenous extracorporeal membrane oxygenation (V-V ECMO)", section on 'Clinical applications'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/134279.html" rel="external">
          "Extracorporeal life support in adults: Management of venoarterial extracorporeal membrane oxygenation (V-A ECMO)", section on 'Clinical applications'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Contraindications to both V-V and V-A ECMO are listed on the table  (
         <a class="graphic graphic_table graphicRef140303" href="/z/d/graphic/140303.html" rel="external">
          table 2
         </a>
         ). (See
         <a class="local">
          'Contraindications'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Cannulation and configuration issues
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Infectious precautions
         </strong>
         –
         <strong>
         </strong>
         Use of an airborne isolation room (ie, negative pressure room) is ideal, and full personal protective equipment (PPE) is necessary for vascular cannulation in a patient with COVID-19 in whom ECMO is planned.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Configurations
         </strong>
         – For V-V ECMO, most experts use a two-site femoral vein-internal jugular vein approach if feasible, similar to that used for most non-COVID-19 patients  (
         <a class="graphic graphic_figure graphicRef140301" href="/z/d/graphic/140301.html" rel="external">
          figure 1
         </a>
         ). Similarly, for V-A ECMO, we suggest femoral venous drainage and femoral or subclavian arterial reinfusion  (
         <a class="graphic graphic_figure graphicRef140295" href="/z/d/graphic/140295.html" rel="external">
          figure 2
         </a>
         ). These configurations are preferred in patients with COVID-19 since cannulation is often needed under urgent or emergent circumstances and these vessels are percutaneously accessible at the bedside. In addition, they obviate the need for patient transport to a fluoroscopy suite, which increases the risk of virus transmission. (See
         <a class="local">
          'Catheter configurations and cannulation'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         These and other commonly used options for patients with COVID-19 are shown in the table  (
         <a class="graphic graphic_table graphicRef128250" href="/z/d/graphic/128250.html" rel="external">
          table 3
         </a>
         ), and discussed in detail separately.
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/134266.html" rel="external">
          "Extracorporeal life support in adults: Management of venovenous extracorporeal membrane oxygenation (V-V ECMO)", section on 'Catheter insertion'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/134279.html" rel="external">
          "Extracorporeal life support in adults: Management of venoarterial extracorporeal membrane oxygenation (V-A ECMO)", section on 'Catheter insertion'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Maintenance of ECMO support
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Oxygenation and ventilation
         </strong>
         – Goals for maintaining oxygenation and ventilation during ECMO are the same as for non-COVID-19 patients on V-V ECMO. (See
         <a class="local">
          'COVID-specific concerns for ECMO management'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Anticoagulation strategies
         </strong>
         – All patients require anticoagulation due to the high risk of thrombosis. Our strategy is similar to that for non-COVID-19 patients. We use a continuous infusion of
         <a class="drug drug_general" data-topicid="8518" href="/z/d/drug information/8518.html" rel="external">
          unfractionated heparin
         </a>
         to target an activated partial thromboplastin time (aPTT) that is at least 1.5 times the institutional control value for V-V ECMO or 2.0 times the control value for V-A ECMO; some experts use higher targets. (See
         <a class="local">
          'Maintenance of anticoagulation'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Others
         </strong>
         – Other maintenance issues are discussed separately in other ECMO topics:
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         <strong>
          Sedation
         </strong>
         – (See
         <a class="local">
          'Sedation'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/134266.html" rel="external">
          "Extracorporeal life support in adults: Management of venovenous extracorporeal membrane oxygenation (V-V ECMO)", section on 'Routine measures'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/127419.html" rel="external">
          "COVID-19: Management of the intubated adult", section on 'Sedation and analgesia'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         <strong>
          Prone positioning
         </strong>
         – (See
         <a class="local">
          'Prone positioning'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         <strong>
          V-V to V-A ECMO conversion
         </strong>
         – (See
         <a class="local">
          'V-V to V-A ECMO conversion'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/134266.html" rel="external">
          "Extracorporeal life support in adults: Management of venovenous extracorporeal membrane oxygenation (V-V ECMO)", section on 'Managing concomitant cardiac failure'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         <strong>
          Tracheostomy
         </strong>
         – (See
         <a class="medical medical_review" href="/z/d/html/127419.html" rel="external">
          "COVID-19: Management of the intubated adult", section on 'Tracheostomy'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/4389.html" rel="external">
          "Tracheostomy: Rationale, indications, and contraindications", section on 'COVID-19'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/131519.html" rel="external">
          "Tracheostomy in adults: Techniques and intraoperative complications", section on 'COVID-19'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         <strong>
          Weaning
         </strong>
         – Our institutional weaning protocols are shown in the algorithms  (
         <a class="graphic graphic_algorithm graphicRef128540" href="/z/d/graphic/128540.html" rel="external">
          algorithm 1
         </a>
         and
         <a class="graphic graphic_algorithm graphicRef131446" href="/z/d/graphic/131446.html" rel="external">
          algorithm 2
         </a>
         ). (See
         <a class="local">
          'Duration of support and ECMO weaning'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Complications
         </strong>
         – Rates of bleeding and possibly thrombosis may be higher in patients with COVID-19 than in non-COVID-19 patients on ECMO support. (See
         <a class="local">
          'Complications'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         These and other complications are discussed in other ECMO topics  (
         <a class="graphic graphic_table graphicRef140676" href="/z/d/graphic/140676.html" rel="external">
          table 4
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/1625.html" rel="external">
          "Extracorporeal life support in adults in the intensive care unit: Overview", section on 'Complications'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/134266.html" rel="external">
          "Extracorporeal life support in adults: Management of venovenous extracorporeal membrane oxygenation (V-V ECMO)", section on 'Complications'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/134279.html" rel="external">
          "Extracorporeal life support in adults: Management of venoarterial extracorporeal membrane oxygenation (V-A ECMO)", section on 'V-A ECMO-specific complications'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Prognosis
         </strong>
         – Risk for mortality and typical sequalae such as ARDS and post-intensive care syndrome (PICS) after ECMO support are comparable or slightly higher in patients with COVID-19 compared with those without COVID-19. (See
         <a class="local">
          'Prognosis'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/1625.html" rel="external">
          "Extracorporeal life support in adults in the intensive care unit: Overview", section on 'Prognosis and long-term outcomes'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/1601.html" rel="external">
          "Acute respiratory distress syndrome: Prognosis and outcomes in adults"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/88330.html" rel="external">
          "Post-intensive care syndrome (PICS) in adults: Clinical features and diagnostic evaluation"
         </a>
         .)
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Bartlett RH, Ogino MT, Brodie D, et al. Initial ELSO Guidance Document: ECMO for COVID-19 Patients with Severe Cardiopulmonary Failure. ASAIO J 2020; 66:472.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ramanathan K, Antognini D, Combes A, et al. Planning and provision of ECMO services for severe ARDS during the COVID-19 pandemic and other outbreaks of emerging infectious diseases. Lancet Respir Med 2020; 8:518.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rajagopal K, Keller SP, Akkanti B, et al. Advanced Pulmonary and Cardiac Support of COVID-19 Patients: Emerging Recommendations From ASAIO-a Living Working Document. Circ Heart Fail 2020; 13:e007175.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Matthay MA, Aldrich JM, Gotts JE. Treatment for severe acute respiratory distress syndrome from COVID-19. Lancet Respir Med 2020; 8:433.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zeng Y, Cai Z, Xianyu Y, et al. Prognosis when using extracorporeal membrane oxygenation (ECMO) for critically ill COVID-19 patients in China: a retrospective case series. Crit Care 2020; 24:148.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           MacLaren G, Fisher D, Brodie D. Treating the Most Critically Ill Patients With COVID-19: The Evolving Role of Extracorporeal Membrane Oxygenation. JAMA 2022; 327:31.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Diaz RA, Graf J, Zambrano JM, et al. Extracorporeal Membrane Oxygenation for COVID-19-associated Severe Acute Respiratory Distress Syndrome in Chile: A Nationwide Incidence and Cohort Study. Am J Respir Crit Care Med 2021; 204:34.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shekar K, Badulak J, Peek G, et al. Extracorporeal Life Support Organization Coronavirus Disease 2019 Interim Guidelines: A Consensus Document from an International Group of Interdisciplinary Extracorporeal Membrane Oxygenation Providers. ASAIO J 2020; 66:707.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Munshi L, Brodie D, Fan E. Extracorporeal support for acute respiratory distress syndrome in adults. NEJM Evid 2022; 1:2200128.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Li X, Guo Z, Li B, et al. Extracorporeal Membrane Oxygenation for Coronavirus Disease 2019 in Shanghai, China. ASAIO J 2020; 66:475.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sanford Z, Madathil RJ, Deatrick KB, et al. Extracorporeal Membrane Oxygenation for COVID-19. Innovations (Phila) 2020; 15:306.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jacobs JP, Stammers AH, St Louis J, et al. Extracorporeal Membrane Oxygenation in the Treatment of Severe Pulmonary and Cardiac Compromise in Coronavirus Disease 2019: Experience with 32 Patients. ASAIO J 2020; 66:722.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yang X, Yu Y, Xu J, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med 2020; 8:475.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Al Gazwi HA, Ibrahim EE, Al Hammad ZA, Al Robeh ZA. Extracorporeal Membrane Oxygenation in Severe ARDS Secondary to Middle East Respiratory Syndrome Coronavirus. Respiratory Care 64.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Alshahrani MS, Sindi A, Alshamsi F, et al. Extracorporeal membrane oxygenation for severe Middle East respiratory syndrome coronavirus. Ann Intensive Care 2018; 8:3.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sukhal S, Sethi J, Ganesh M, et al. Extracorporeal membrane oxygenation in severe influenza infection with respiratory failure: A systematic review and meta-analysis. Ann Card Anaesth 2017; 20:14.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zangrillo A, Biondi-Zoccai G, Landoni G, et al. Extracorporeal membrane oxygenation (ECMO) in patients with H1N1 influenza infection: a systematic review and meta-analysis including 8 studies and 266 patients receiving ECMO. Crit Care 2013; 17:R30.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Patroniti N, Zangrillo A, Pappalardo F, et al. The Italian ECMO network experience during the 2009 influenza A(H1N1) pandemic: preparation for severe respiratory emergency outbreaks. Intensive Care Med 2011; 37:1447.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hoyler MM, Flynn B, Iannacone EM, et al. Clinical Management of Venoarterial Extracorporeal Membrane Oxygenation. J Cardiothorac Vasc Anesth 2020; 34:2776.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shelton KT, Wiener-Kronish JP. Evolving Role of Anesthesiology Intensivists in Cardiothoracic Critical Care. Anesthesiology 2020; 133:1120.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020; 395:507.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Osho AA, Moonsamy P, Hibbert KA, et al. Veno-venous Extracorporeal Membrane Oxygenation for Respiratory Failure in COVID-19 Patients: Early Experience From a Major Academic Medical Center in North America. Ann Surg 2020.
          </a>
         </li>
         <li class="breakAll">
          Centers for Disease Control: Interim Infection Prevention and Control Recommendations for Patients with Suspected or Confirmed Coronavirus Disease 2019 (COVID-19) in Healthcare Settings https://www.cdc.gov/coronavirus/2019-ncov/hcp/infection-control-recommendations.html (Accessed on May 20, 2020).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kirkpatrick JN, Mitchell C, Taub C, et al. ASE Statement on Protection of Patients and Echocardiography Service Providers During the 2019 Novel Coronavirus Outbreak: Endorsed by the American College of Cardiology. J Am Coll Cardiol 2020; 75:3078.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Augoustides JG. Perioperative Echocardiography: Key Considerations During the Coronavirus Pandemic. J Cardiothorac Vasc Anesth 2020; 34:1416.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wood DA, Mahmud E, Thourani VH, et al. Safe Reintroduction of Cardiovascular Services During the COVID-19 Pandemic: From the North American Society Leadership. J Am Coll Cardiol 2020; 75:3177.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Markin NW, Cawcutt KA, Sayyed SH, et al. Transesophageal Echocardiography Probe Sheath to Decrease Provider and Environment Contamination. Anesthesiology 2020; 133:475.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nicoara A, Maldonado Y, Kort S, et al. Specific Considerations for the Protection of Patients and Echocardiography Service Providers When Performing Perioperative or Periprocedural Transesophageal Echocardiography during the 2019 Novel Coronavirus Outbreak: Council on Perioperative Echocardiography Supplement to the Statement of the American Society of Echocardiography Endorsed by the Society of Cardiovascular Anesthesiologists. J Am Soc Echocardiogr 2020; 33:666.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Teran F, Burns KM, Narasimhan M, et al. Critical Care Transesophageal Echocardiography in Patients during the COVID-19 Pandemic. J Am Soc Echocardiogr 2020; 33:1040.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Beyls C, Huette P, Abou-Arab O, et al. Extracorporeal membrane oxygenation for COVID-19-associated severe acute respiratory distress syndrome and risk of thrombosis. Br J Anaesth 2020; 125:e260.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Guo Z, Sun L, Li B, et al. Anticoagulation Management in Severe Coronavirus Disease 2019 Patients on Extracorporeal Membrane Oxygenation. J Cardiothorac Vasc Anesth 2021; 35:389.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Panigada M, Bottino N, Tagliabue P, et al. Hypercoagulability of COVID-19 patients in intensive care unit: A report of thromboelastography findings and other parameters of hemostasis. J Thromb Haemost 2020; 18:1738.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Usman AA, Han J, Acker A, et al. A Case Series of Devastating Intracranial Hemorrhage During Venovenous Extracorporeal Membrane Oxygenation for COVID-19. J Cardiothorac Vasc Anesth 2020; 34:3006.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Seelhammer TG, Plack D, Lal A, Nabzdyk CGS. COVID-19 and ECMO: An Unhappy Marriage of Endothelial Dysfunction and Hemostatic Derangements. J Cardiothorac Vasc Anesth 2020; 34:3193.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Koster A, Ljajikj E, Faraoni D. Traditional and non-traditional anticoagulation management during extracorporeal membrane oxygenation. Ann Cardiothorac Surg 2019; 8:129.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hellmann C, Schmutz A, Kalbhenn J. Bleeding during veno-venous ECMO cannot reliably be predicted by rotational thrombelastometry (ROTEM™). Perfusion 2018; 33:289.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hekimian G, Brechot N, Luyt C-E, et al. Severe pulmonary embolism in COVID-19 patients: a call for increased awareness. Crit Care 2020; (in press).
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hanidziar D, Bittner EA. Sedation of Mechanically Ventilated COVID-19 Patients: Challenges and Special Considerations. Anesth Analg 2020; 131:e40.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Blanch L, Villagra A, Sales B, et al. Asynchronies during mechanical ventilation are associated with mortality. Intensive Care Med 2015; 41:633.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Martyn JAJ, Mao J, Bittner EA. Opioid Tolerance in Critical Illness. N Engl J Med 2019; 380:365.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Garcia B, Cousin N, Bourel C, et al. Prone positioning under VV-ECMO in SARS-CoV-2-induced acute respiratory distress syndrome. Crit Care 2020; 24:428.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kimmoun A, Roche S, Bridey C, et al. Prolonged prone positioning under VV-ECMO is safe and improves oxygenation and respiratory compliance. Ann Intensive Care 2015; 5:35.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Poon WH, Ramanathan K, Ling RR, et al. Prone positioning during venovenous extracorporeal membrane oxygenation for acute respiratory distress syndrome: a systematic review and meta-analysis. Crit Care 2021; 25:292.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Liu C, Chen Y, Chen Y, et al. Effects of prone positioning during extracorporeal membrane oxygenation for refractory respiratory failure: a systematic review. SN Compr Clin Med 2021; 3:2109.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chow JH, Mazzeffi MA, McCurdy MT. Angiotensin II for the Treatment of COVID-19-Related Vasodilatory Shock. Anesth Analg 2020; 131:102.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Xie Y, Wang X, Yang P, Zhang S. COVID-19 Complicated by Acute Pulmonary Embolism. Radiol Cardiothorac Imaging 2020; 2:e200067.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Danzi GB, Loffi M, Galeazzi G, Gherbesi E. Acute pulmonary embolism and COVID-19 pneumonia: a random association? Eur Heart J 2020; 41:1858.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Augoustides JGT. Cardiovascular consequences and considerations of cornavirus infection - perspectives for the cardiothoracic anesthesiologist and intensivist during the coronavirus crisis. J Cardiothorac Vasc Anesth 2020; (in press).
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Portugal LG, Adams DR, Baroody FM, Agrawal N. A Surgical Safety Checklist for Performing Tracheotomy in Patients with Coronavirus Disease 19. Otolaryngol Head Neck Surg 2020; 163:42.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mustafa AK, Alexander PJ, Joshi DJ, et al. Extracorporeal Membrane Oxygenation for Patients With COVID-19 in Severe Respiratory Failure. JAMA Surg 2020; 155:990.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Quintel M, Bartlett RH, Grocott MPW, et al. Extracorporeal Membrane Oxygenation for Respiratory Failure. Anesthesiology 2020; 132:1257.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lang C, Ritschl V, Augustin F, et al. Clinical relevance of lung transplantation for COVID-19 ARDS: a nationwide study. Eur Respir J 2022.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mansour A, Flecher E, Schmidt M, et al. Bleeding and thrombotic events in patients with severe COVID-19 supported with extracorporeal membrane oxygenation: a nationwide cohort study. Intensive Care Med 2022; 48:1039.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Williams B, Bernstein W. Review of Venoarterial Extracorporeal Membrane Oxygenation and Development of Intracardiac Thrombosis in Adult Cardiothoracic Patients. J Extra Corpor Technol 2016; 48:162.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hu D, Liu K, Li B, Hu Z. Large intracardiac thrombus in a COVID-19 patient treated with prolonged extracorporeal membrane oxygenation implantation. Eur Heart J 2020; 41:3104.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schmiady MO, Sromicki J, Kucher N, Ouda A. Successful percutaneous thrombectomy in a patient with COVID-19 pneumonia and acute pulmonary embolism supported by extracorporeal membrane oxygenation. Eur Heart J 2020; 41:3107.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ñamendys-Silva SA. ECMO for ARDS due to COVID-19. Heart Lung 2020; 49:348.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Henry BM, Lippi G. Poor survival with extracorporeal membrane oxygenation in acute respiratory distress syndrome (ARDS) due to coronavirus disease 2019 (COVID-19): Pooled analysis of early reports. J Crit Care 2020; 58:27.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Barbaro RP, MacLaren G, Boonstra PS, et al. Extracorporeal membrane oxygenation for COVID-19: evolving outcomes from the international Extracorporeal Life Support Organization Registry. Lancet 2021; 398:1230.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Barbaro RP, MacLaren G, Boonstra PS, et al. Extracorporeal membrane oxygenation support in COVID-19: an international cohort study of the Extracorporeal Life Support Organization registry. Lancet 2020; 396:1071.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schmidt M, Hajage D, Lebreton G, et al. Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome associated with COVID-19: a retrospective cohort study. Lancet Respir Med 2020; 8:1121.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yang X, Cai S, Luo Y, et al. Extracorporeal Membrane Oxygenation for Coronavirus Disease 2019-Induced Acute Respiratory Distress Syndrome: A Multicenter Descriptive Study. Crit Care Med 2020; 48:1289.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shaefi S, Brenner SK, Gupta S, et al. Extracorporeal membrane oxygenation in patients with severe respiratory failure from COVID-19. Intensive Care Med 2021; 47:208.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Biancari F, Mariscalco G, Dalén M, et al. Six-Month Survival After Extracorporeal Membrane Oxygenation for Severe COVID-19. J Cardiothorac Vasc Anesth 2021; 35:1999.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bertini P, Guarracino F, Falcone M, et al. ECMO in COVID-19 Patients: A Systematic Review and Meta-analysis. J Cardiothorac Vasc Anesth 2022; 36:2700.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Urner M, Barnett AG, Bassi GL, et al. Venovenous extracorporeal membrane oxygenation in patients with acute covid-19 associated respiratory failure: comparative effectiveness study. BMJ 2022; 377:e068723.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Barbaro RP, Odetola FO, Kidwell KM, et al. Association of hospital-level volume of extracorporeal membrane oxygenation cases and mortality. Analysis of the extracorporeal life support organization registry. Am J Respir Crit Care Med 2015; 191:894.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tran A, Fernando SM, Rochwerg B, et al. Prognostic factors associated with mortality among patients receiving venovenous extracorporeal membrane oxygenation for COVID-19: a systematic review and meta-analysis. Lancet Respir Med 2023; 11:235.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bhatraju PK, Ghassemieh BJ, Nichols M, et al. Covid-19 in Critically Ill Patients in the Seattle Region - Case Series. N Engl J Med 2020; 382:2012.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rajajee V, Fung CM, Seagly KS, et al. One-Year Functional, Cognitive, and Psychological Outcomes Following the Use of Extracorporeal Membrane Oxygenation in Coronavirus Disease 2019: A Prospective Study. Crit Care Explor 2021; 3:e0537.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Palella S, Muscarà L, La Via L, Sanfilippo F. Veno-venous extracorporeal membrane oxygenation for rescue support in pregnant patients with COVID-19: a systematic review. Br J Anaesth 2023; 131:e130.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           MacLaren G, Fisher D, Brodie D. Preparing for the Most Critically Ill Patients With COVID-19: The Potential Role of Extracorporeal Membrane Oxygenation. JAMA 2020; 323:1245.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Parhar KKS, Lequier L, Blackwood J, et al. Optimizing provision of extracorporeal life support during the COVID-19 pandemic: practical considerations for Canadian jurisdictions. CMAJ 2020; 192:E372.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Harvey MJ, Gaies MG, Prosser LA. U.S. and International In-Hospital Costs of Extracorporeal Membrane Oxygenation: a Systematic Review. Appl Health Econ Health Policy 2015; 13:341.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zochios V, Brodie D, Charlesworth M, Parhar KK. Delivering extracorporeal membrane oxygenation for patients with COVID-19: what, who, when and how? Anaesthesia 2020; 75:997.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nurok M, Pellegrino V, Pineton de Chambrun M, et al. It's Not Just the Prices: Time-Driven Activity-Based Costing for Initiation of Veno-Venous Extracorporeal Membrane Oxygenation at Three International Sites-A Case Review. Anesth Analg 2022; 135:711.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hamele M, Neumayer K, Sweney J, Poss WB. Always ready, always prepared-preparing for the next pandemic. Transl Pediatr 2018; 7:344.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Augoustides JGT. Extracorporeal membrane oxygenation - Crucial considerations during the coronavirus crisis. J Cardiothorac Vasc Anesth 2020; (in press).
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Augoustides JG. Extracorporeal Membrane Oxygenation - Crucial Considerations during the Coronavirus Crisis. J Cardiothorac Vasc Anesth 2020; 34:1720.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 127765 Version 24.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32243267" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Initial ELSO Guidance Document: ECMO for COVID-19 Patients with Severe Cardiopulmonary Failure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32203711" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Planning and provision of ECMO services for severe ARDS during the COVID-19 pandemic and other outbreaks of emerging infectious diseases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32357074" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Advanced Pulmonary and Cardiac Support of COVID-19 Patients: Emerging Recommendations From ASAIO-a Living Working Document.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32203709" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Treatment for severe acute respiratory distress syndrome from COVID-19.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32293518" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Prognosis when using extracorporeal membrane oxygenation (ECMO) for critically ill COVID-19 patients in China: a retrospective case series.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34919122" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Treating the Most Critically Ill Patients With COVID-19: The Evolving Role of Extracorporeal Membrane Oxygenation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33823118" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Extracorporeal Membrane Oxygenation for COVID-19-associated Severe Acute Respiratory Distress Syndrome in Chile: A Nationwide Incidence and Cohort Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32604322" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Extracorporeal Life Support Organization Coronavirus Disease 2019 Interim Guidelines: A Consensus Document from an International Group of Interdisciplinary Extracorporeal Membrane Oxygenation Providers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Extracorporeal support for acute respiratory distress syndrome in adults
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32243266" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Extracorporeal Membrane Oxygenation for Coronavirus Disease 2019 in Shanghai, China.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32692258" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Extracorporeal Membrane Oxygenation for COVID-19.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32317557" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Extracorporeal Membrane Oxygenation in the Treatment of Severe Pulmonary and Cardiac Compromise in Coronavirus Disease 2019: Experience with 32 Patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32105632" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Extracorporeal Membrane Oxygenation in Severe ARDS Secondary to Middle East Respiratory Syndrome Coronavirus
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29330690" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Extracorporeal membrane oxygenation for severe Middle East respiratory syndrome coronavirus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28074789" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Extracorporeal membrane oxygenation in severe influenza infection with respiratory failure: A systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23406535" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Extracorporeal membrane oxygenation (ECMO) in patients with H1N1 influenza infection: a systematic review and meta-analysis including 8 studies and 266 patients receiving ECMO.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21732167" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : The Italian ECMO network experience during the 2009 influenza A(H1N1) pandemic: preparation for severe respiratory emergency outbreaks.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32139341" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Clinical Management of Venoarterial Extracorporeal Membrane Oxygenation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32501959" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Evolving Role of Anesthesiology Intensivists in Cardiothoracic Critical Care.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32007143" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32452947" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Veno-venous Extracorporeal Membrane Oxygenation for Respiratory Failure in COVID-19 Patients: Early Experience From a Major Academic Medical Center in North America.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32452947" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Veno-venous Extracorporeal Membrane Oxygenation for Respiratory Failure in COVID-19 Patients: Early Experience From a Major Academic Medical Center in North America.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32272153" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : ASE Statement on Protection of Patients and Echocardiography Service Providers During the 2019 Novel Coronavirus Outbreak: Endorsed by the American College of Cardiology.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32249075" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Perioperative Echocardiography: Key Considerations During the Coronavirus Pandemic.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32380033" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Safe Reintroduction of Cardiovascular Services During the COVID-19 Pandemic: From the North American Society Leadership.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32358249" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Transesophageal Echocardiography Probe Sheath to Decrease Provider and Environment Contamination.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32503703" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Specific Considerations for the Protection of Patients and Echocardiography Service Providers When Performing Perioperative or Periprocedural Transesophageal Echocardiography during the 2019 Novel Coronavirus Outbreak: Council on Perioperative Echocardiography Supplement to the Statement of the American Society of Echocardiography Endorsed by the Society of Cardiovascular Anesthesiologists.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32600742" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Critical Care Transesophageal Echocardiography in Patients during the COVID-19 Pandemic.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32414510" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Extracorporeal membrane oxygenation for COVID-19-associated severe acute respiratory distress syndrome and risk of thrombosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32994131" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Anticoagulation Management in Severe Coronavirus Disease 2019 Patients on Extracorporeal Membrane Oxygenation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32302438" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Hypercoagulability of COVID-19 patients in intensive care unit: A report of thromboelastography findings and other parameters of hemostasis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32828653" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : A Case Series of Devastating Intracranial Hemorrhage During Venovenous Extracorporeal Membrane Oxygenation for COVID-19.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33228917" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : COVID-19 and ECMO: An Unhappy Marriage of Endothelial Dysfunction and Hemostatic Derangements.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30854322" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Traditional and non-traditional anticoagulation management during extracorporeal membrane oxygenation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29188749" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Bleeding during veno-venous ECMO cannot reliably be predicted by rotational thrombelastometry (ROTEM™).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Severe pulmonary embolism in COVID-19 patients: a call for increased awareness
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32392023" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Sedation of Mechanically Ventilated COVID-19 Patients: Challenges and Special Considerations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25693449" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Asynchronies during mechanical ventilation are associated with mortality.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30673555" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Opioid Tolerance in Critical Illness.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32665007" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Prone positioning under VV-ECMO in SARS-CoV-2-induced acute respiratory distress syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26538308" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Prolonged prone positioning under VV-ECMO is safe and improves oxygenation and respiratory compliance.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34384475" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Prone positioning during venovenous extracorporeal membrane oxygenation for acute respiratory distress syndrome: a systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34308257" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Effects of prone positioning during extracorporeal membrane oxygenation for refractory respiratory failure: a systematic review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32209811" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Angiotensin II for the Treatment of COVID-19-Related Vasodilatory Shock.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33778561" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : COVID-19 Complicated by Acute Pulmonary Embolism.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32227120" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Acute pulmonary embolism and COVID-19 pneumonia: a random association?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Cardiovascular consequences and considerations of cornavirus infection - perspectives for the cardiothoracic anesthesiologist and intensivist during the coronavirus crisis
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32340546" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : A Surgical Safety Checklist for Performing Tracheotomy in Patients with Coronavirus Disease 19.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32780089" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Extracorporeal Membrane Oxygenation for Patients With COVID-19 in Severe Respiratory Failure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32149776" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Extracorporeal Membrane Oxygenation for Respiratory Failure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35301249" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : Clinical relevance of lung transplantation for COVID-19 ARDS: a nationwide study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35829723" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Bleeding and thrombotic events in patients with severe COVID-19 supported with extracorporeal membrane oxygenation: a nationwide cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27994255" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Review of Venoarterial Extracorporeal Membrane Oxygenation and Development of Intracardiac Thrombosis in Adult Cardiothoracic Patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32607534" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Large intracardiac thrombus in a COVID-19 patient treated with prolonged extracorporeal membrane oxygenation implantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32396627" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Successful percutaneous thrombectomy in a patient with COVID-19 pneumonia and acute pulmonary embolism supported by extracorporeal membrane oxygenation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32223988" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : ECMO for ARDS due to COVID-19.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32279018" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Poor survival with extracorporeal membrane oxygenation in acute respiratory distress syndrome (ARDS) due to coronavirus disease 2019 (COVID-19): Pooled analysis of early reports.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34599878" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Extracorporeal membrane oxygenation for COVID-19: evolving outcomes from the international Extracorporeal Life Support Organization Registry.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32987008" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : Extracorporeal membrane oxygenation support in COVID-19: an international cohort study of the Extracorporeal Life Support Organization registry.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32798468" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome associated with COVID-19: a retrospective cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32427613" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : Extracorporeal Membrane Oxygenation for Coronavirus Disease 2019-Induced Acute Respiratory Distress Syndrome: A Multicenter Descriptive Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33528595" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : Extracorporeal membrane oxygenation in patients with severe respiratory failure from COVID-19.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33573928" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : Six-Month Survival After Extracorporeal Membrane Oxygenation for Severe COVID-19.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34906383" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : ECMO in COVID-19 Patients: A Systematic Review and Meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35508314" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : Venovenous extracorporeal membrane oxygenation in patients with acute covid-19 associated respiratory failure: comparative effectiveness study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25695688" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : Association of hospital-level volume of extracorporeal membrane oxygenation cases and mortality. Analysis of the extracorporeal life support organization registry.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36228638" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : Prognostic factors associated with mortality among patients receiving venovenous extracorporeal membrane oxygenation for COVID-19: a systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32227758" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : Covid-19 in Critically Ill Patients in the Seattle Region - Case Series.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34589715" id="rid69" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          70 : One-Year Functional, Cognitive, and Psychological Outcomes Following the Use of Extracorporeal Membrane Oxygenation in Coronavirus Disease 2019: A Prospective Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/37544839" id="rid70" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          71 : Veno-venous extracorporeal membrane oxygenation for rescue support in pregnant patients with COVID-19: a systematic review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32074258" id="rid71" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          72 : Preparing for the Most Critically Ill Patients With COVID-19: The Potential Role of Extracorporeal Membrane Oxygenation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32336679" id="rid72" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          73 : Optimizing provision of extracorporeal life support during the COVID-19 pandemic: practical considerations for Canadian jurisdictions.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25894740" id="rid73" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          74 : U.S. and International In-Hospital Costs of Extracorporeal Membrane Oxygenation: a Systematic Review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32319081" id="rid74" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          75 : Delivering extracorporeal membrane oxygenation for patients with COVID-19: what, who, when and how?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35648049" id="rid75" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          76 : It's Not Just the Prices: Time-Driven Activity-Based Costing for Initiation of Veno-Venous Extracorporeal Membrane Oxygenation at Three International Sites-A Case Review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30460186" id="rid76" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          77 : Always ready, always prepared-preparing for the next pandemic.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid77" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          78 : Extracorporeal membrane oxygenation - Crucial considerations during the coronavirus crisis
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32345529" id="rid78" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          79 : Extracorporeal Membrane Oxygenation - Crucial Considerations during the Coronavirus Crisis.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
